ZA892911B - Compounds useful in the treatment and diagnosis of erectile dysfunctions - Google Patents

Compounds useful in the treatment and diagnosis of erectile dysfunctions

Info

Publication number
ZA892911B
ZA892911B ZA892911A ZA892911A ZA892911B ZA 892911 B ZA892911 B ZA 892911B ZA 892911 A ZA892911 A ZA 892911A ZA 892911 A ZA892911 A ZA 892911A ZA 892911 B ZA892911 B ZA 892911B
Authority
ZA
South Africa
Prior art keywords
diagnosis
treatment
compounds useful
erectile dysfunctions
dysfunctions
Prior art date
Application number
ZA892911A
Inventor
Ralf Ruffmann
Ruffmann Ralf
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of ZA892911B publication Critical patent/ZA892911B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
ZA892911A 1988-04-22 1989-04-20 Compounds useful in the treatment and diagnosis of erectile dysfunctions ZA892911B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20299/88A IT1217190B (en) 1988-04-22 1988-04-22 USEFUL COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF HURRY DYSFUNCTIONS

Publications (1)

Publication Number Publication Date
ZA892911B true ZA892911B (en) 1989-12-27

Family

ID=11165532

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA892911A ZA892911B (en) 1988-04-22 1989-04-20 Compounds useful in the treatment and diagnosis of erectile dysfunctions

Country Status (8)

Country Link
EP (1) EP0374210A1 (en)
JP (1) JPH02504146A (en)
KR (1) KR900700098A (en)
AU (1) AU3438289A (en)
HU (1) HU202754B (en)
IT (1) IT1217190B (en)
WO (1) WO1989010123A1 (en)
ZA (1) ZA892911B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
GB9514465D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
GB9423910D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9423911D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514464D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
YU49898A (en) * 1996-05-10 2000-03-21 Icos Corporation Chemical compounds
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
EP1442042A1 (en) 2001-11-09 2004-08-04 Schering Corporation Polycyclic guanine derivative phosphodiesterase v inhibitors
WO2011023287A1 (en) * 2009-08-27 2011-03-03 Merck Patent Gmbh Use of faa and its derivatives in cosmetics and dermatology

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent

Also Published As

Publication number Publication date
WO1989010123A1 (en) 1989-11-02
JPH02504146A (en) 1990-11-29
AU3438289A (en) 1989-11-24
HUT53804A (en) 1990-12-28
EP0374210A1 (en) 1990-06-27
KR900700098A (en) 1990-08-11
IT8820299A0 (en) 1988-04-22
IT1217190B (en) 1990-03-14
HU892651D0 (en) 1990-11-28
HU202754B (en) 1991-04-29

Similar Documents

Publication Publication Date Title
EP0428188A3 (en) Novel immunoconjugates and methods for their use in tumor therapy
EP0349235A3 (en) Niacin-containing composition and its therapeutic use
JPS6454092A (en) Solid scintillator and its treatment
EP0243968A3 (en) Diacetylrhein salts and their therapeutical use in the treatment of arthritis
EP0278173A3 (en) Use of heterocyclic derivatives in the treatment of depressions
JPS6454032A (en) Polydisilacyclobutasilazane and its preparation and use
EP0584340A4 (en) Diagnosis and treatment of various neuralgias
ZA892911B (en) Compounds useful in the treatment and diagnosis of erectile dysfunctions
NZ223382A (en) Triazinetriones and their use in treating protozoa in insects
GB2223225B (en) Neutrophil-activating factor: its production and use in treatment
GB8825988D0 (en) Device for use in treatment of lymphocytes
EP0255801A3 (en) Anilinotriazines and their use
EP0437026A3 (en) Use of tandospirone in the treatment of depression
GB2203645B (en) Improvements in the treatment of hair
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
GB2212779B (en) Improvements in badges and the like
GB8908843D0 (en) Improvements in or relating to the treatment of surfaces
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
ZA899304B (en) Use of benzopyran derivatives in the treatment of epilepsy
EP0254777A3 (en) Use of imidazolinylaminoisoindolines and related compounds in the treatment of hyperglycaemia
EP0407016A3 (en) Use of benzodioxinopyrrole derivatives in the treatment of anxiety
EP0318202A3 (en) Catalysts and their use in the hydrolysis of nitriles
ZA87873B (en) Substituted diazapines and derivatives thereof useful in the treatment of cardiovascular disorders
IL89998A0 (en) Use of gonadoliberin derivatives in the treatment of tumours
SG4695G (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases